While we did not have sufficient data available on exact dates of testing to complete a specific analysis in our population, one study of test utilization in BC patients showed a shift from 74% BRCA1/2 only in 2013 to 33.5% BRCA1/2 only by 201537. The gene discussed is BRCA1; the disease is breast cancer.